Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Heartflow, Inc. (HTFL)

59.05 -1.48 (-2.45%)
At close: October 30 at 4:00:01 PM EDT
58.00 -1.05 (-1.78%)
After hours: October 30 at 6:46:21 PM EDT
Trade HTFL on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. John C.M. Farquhar
President, CEO & Director 1.44M -- 1973
Mr. Vikram Verghese C.F.A.
Chief Financial Officer 757.92k -- 1985
Dr. Campbell D.K. Rogers FACC, M.D.
Chief Medical Officer & Executive VP 1.1M -- 1961
Dr. John Henry Stevens M.D.
Co-Founder -- -- 1961
Ms. Kathleen Carey
Senior Vice President of Operations -- -- --
Mhairi L. Jones
Chief Accounting Officer -- -- --
Mr. Justin Cambra
Chief Technology Officer -- -- --
Mr. Nicholas S. Laudico
Vice President of Investor Relations -- -- --
Ms. Angela Ahmad J.D.
Chief Legal & Compliance Officer -- -- --
Mr. Shivanth Bhaskaran
Chief Commercial Operations & Customer Success Officer -- -- --

Heartflow, Inc.

135 Main Street
Suite 1000
San Francisco, CA 94105
United States
650 241 1221 https://www.heartflow.com
Sector: 
Healthcare
Full Time Employees: 
843

Description

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Corporate Governance

Heartflow, Inc.’s ISS Governance QualityScore as of October 1, 2026 is 7. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 8; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2026 at 9:00 PM UTC

Heartflow, Inc. Earnings Date

Recent Events

August 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 18, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 29, 2026 at 12:00 AM UTC

ARS: Annual Report to Shareholders

March 18, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

January 12, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 19, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 25, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: